Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.020
-0.040 (-3.77%)
Oct 7, 2025, 4:00 PM EDT - Market closed
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $11.09 million as of October 7, 2025. Its market cap has increased by 56.29% in one year.
Market Cap
11.09M
Enterprise Value
8.85M
1-Year Change
56.29%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $11.09M, a decrease of -68.57%. That is a compound annual growth rate of -25.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 11.31M | 33.88% |
| Dec 31, 2024 | 8.45M | 100.93% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
| Oct 29, 2021 | 35.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |